As expected and consistent with our hypothesis that ICD must first be initiated to enhance the efficacy of immunotherapies, the combination of THT and i.t. IL-2 induced sustained tumor regression (Figures 5A, B) and increased CD8+ T cell infiltration in the TME at the study endpoint (Figure 6A). This evidence concerns the gene IL2 and neoplasm.